about
Vapers' perspectives on electronic cigarette regulation in Australia.Researchers' perspectives on scientific and ethical issues with transcranial direct current stimulation: An international survey.Parental supply of alcohol to Australian minors: an analysis of six nationally representative surveys spanning 15 years.Trend in alcohol use in Australia over 13 years: has there been a trend reversal?Why young people's substance use matters for global health.Lee Robins' studies of heroin use among US Vietnam veterans.The Use of Cannabinoids in Treating Dementia.Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014.Rural and Urban Differences in Adolescent Alcohol Use, Alcohol Supply, and Parental Drinking.Socio-economic differentials in cannabis use trends in Australia.Scepticism and hope in a complex predicament: People with addictions deliberate about neuroscience.Commentary on White et al. (2017): Adolescent drinking and exposure to advertising-behaviour does not occur in a social vacuum.Assessing the place of neurobiological explanations in accounts of a family member's addiction.Moving beyond vaping as a cessation-only practice.The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.Systematic review and meta-analysis of cannabinoids in palliative medicine.Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.Assessing the public health impacts of legalizing recreational cannabis use in the USA.Has Marijuana Legalization Increased Marijuana Use Among US Youth?Reducing alcohol-related violence and other harm in Australia.Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studiesBarriers and facilitators to switching from smoking to vaping: Advice from vapers'Potential issues of morbidity, toxicity and dependence': Problematizing the up-scheduling of over-the-counter codeine in AustraliaMaking markets work for disability services: The question of price setting
P50
Q34464889-8700CBF6-260E-4B0D-9CCB-7FEAFED4D37AQ35727708-70207114-E9D2-466E-9E56-293A8D66F9CBQ35988883-192BE3A9-CBD8-43B4-9F5F-4FD114804679Q36159816-6D1B5E5A-E179-4E2F-92C9-B0BA772D6A44Q38746343-DA441762-E723-4D24-A3E9-5459DB4B22E5Q38959894-51E4FC0B-7D12-4F9A-8AB5-626FCA6404EAQ39385097-879C5349-928A-4774-B2BE-E0D6DBFF6887Q39951521-B54C7DF6-BCD5-4B0E-A5B1-8028BDD237E7Q40320822-5232F6FC-6ECA-44DB-A0B0-045DA3CFF160Q47289948-B84DBB5C-C707-4B32-9588-B7EAAF017E6AQ47622011-D9391C65-B0BB-451B-A1D2-28478C50E32BQ47701732-7DC38DE1-F41C-4903-9610-25D46A5C9122Q48139056-32238009-31D1-4754-BBF8-C7D5BD61BF41Q48179078-6FBA63C7-349D-4A93-842F-8A9DAEE9041CQ50016902-5C1C6544-B395-42BF-9130-9FE2A1428FE3Q50201189-1490AE07-B7C3-42D3-8F07-63A230D77055Q51743734-4E8724C9-C65F-4CA1-BE7E-457699AB469BQ52306753-CE2DE59C-B173-4B0D-97FD-4777971CB70CQ52311456-283B99C7-618A-4659-B959-7462FB164AE2Q53523001-A2393C3F-5BB3-4DF9-966F-92996D12FD5EQ88919594-A92BD1D4-E254-4532-9379-DC13971FCF48Q91444849-89D7C675-B6AF-446A-A205-E35021F59F54Q92294025-638E29A8-A570-4F0E-BD91-E4F90EBEA8ACQ92868400-6920F91B-4D49-4344-AEA8-9A47DA776FEE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Megan Weier
@ast
Megan Weier
@en
Megan Weier
@es
Megan Weier
@nl
type
label
Megan Weier
@ast
Megan Weier
@en
Megan Weier
@es
Megan Weier
@nl
prefLabel
Megan Weier
@ast
Megan Weier
@en
Megan Weier
@es
Megan Weier
@nl
P106
P1153
56526633800
P2798
P31
P496
0000-0001-8957-6003